NCT02877095View on ClinicalTrials.gov

Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

November 7, 2017

Study Completion Date

November 7, 2017

Conditions
Acute Heart Failure
Interventions
DRUG

Furosemide

subcutaneous furosemide delivered via subcutaneous pump

Trial Locations (5)

27705

Duke University Medical Center, Durham

30322

Emory University Hospital, Atlanta

44195

Metro Health System, Cleveland

55905

Mayo Clinic, Rochester

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Adrian Hernandez

OTHER

NCT02877095 - Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot | Biotech Hunter | Biotech Hunter